From: Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery
Variable | Adjuvant chemotherapy group (n = 150) | Adjuvant chemo-radiotherapy group (n = 115) | P value |
---|---|---|---|
Age, year | Â | Â | 0.041 |
 median | 57 | 55 |  |
Gender | Â | Â | 0.311 |
 male | 95 | 65 |  |
 female | 55 | 50 |  |
Hb g/L | Â | Â | 0.025 |
  < 128 | 67 | 68 |  |
  ≥ 128 | 83 | 47 |  |
CEA, ug/mL | Â | Â | 0.083 |
  < 5.00 | 75 | 70 |  |
  ≥ 5.00 | 75 | 45 |  |
Tumor Location from AV, cm | Â | Â | 0.213 |
  < 7.0 | 63 | 58 |  |
  ≥ 7.0 | 87 | 57 |  |
Tumor grade | Â | Â | 0.421 |
 G1 | 11 | 5 |  |
 G2 | 123 | 101 |  |
 G3 | 16 | 9 |  |
Type of surgery | Â | Â | 0.804 |
 Mile’s | 30 | 23 |  |
 Dixon | 117 | 88 |  |
 Hartmann | 3 | 4 |  |
Tumor volume, cm3 | Â | Â | 0.083 |
  < 19 | 68 | 65 |  |
  ≥ 19 | 82 | 50 |  |
Retrieved lymph nodes | Â | Â | 0.174 |
  < 14 | 69 | 63 |  |
  ≥ 14 | 81 | 52 |  |
Lymph vascular invasion | Â | Â | 0.808 |
 yes | 11 | 7 |  |
 no | 139 | 108 |  |
Duration of adjuvant therapy, months | Â | Â | Â |
 median | 5.3 (4.5–6.2) | 5.0 (4.4–6.1) | 0.485 |
Follow-up, months | Â | Â | 0.872 |
 median | 57.1 | 56.4 |  |